دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Editorial Board
doi : 10.1016/S0085-2538(22)00745-1
Volume 102, Issue 5, Supplement, November 2022, Page A1
KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease
How does diabetes cause susceptibility to COVID-19 in the kidney: new clues provided by organoids
YunXia1P. TobyCoates2MasaomiNangaku3
Including APOL1 alleles and ancestry adjustments improve a genome-wide polygenic CKD score
ZhiYu12MatthiasWuttke3
Polyploid tubular cells and chronic kidney disease
LetiziaDe Chiara1PaolaRomagnani12
Antioxidant nanozymes for prevention of diseased kidney from failure
QiunongGuan1CaiganDu1
Endothelium and endothelin: regulators of arterial stiffness and fibrinolysis in ANCA-associated vasculitis
MatthiasBarton12
Barriers to accessing essential medicines for kidney disease in low- and lower middle–income countries|
AnnaFrancis1Muhammad IqbalAbdul Hafidz2Udeme E.Ekrikpo3TitiChen4ErangaWijewickrama5Elliot K.Tannor6GeorgesNakhoul7Michelle M.Y.Wong8NikhilPereira-Kamath9RahulChanchlani10RobertKalyesubula11SabineKaram12VivekKumar13VivianeCalice-Silva1415VivekanandJha16171819
Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)
Ian H.de Boer1KamleshKhunti2TamiSadusky3Katherine R.Tuttle4Joshua J.Neumiller5Connie M.Rhee6Sylvia E.Rosas7PeterRossing89GeorgeBakris10
Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence
PeterRossing12M. LuizaCaramori3Juliana C.N.Chan45Hiddo J.L.Heerspink6ClintHurst7KamleshKhunti8AdrianLiew9Erin D.Michos10Sankar D.Navaneethan1112Wasiu A.Olowu13TamiSadusky14NikhilTandon15Katherine R.Tuttle16ChristophWanner17Katy G.Wilkens18SophiaZoungas19Jonathan C.Craig2021David J.Tunnicliffe2122…Ian H.de Boer25
The kidney matrisome in health, aging, and disease
FranziskaLausecker1RachelLennon12Michael J.Randles3
What can we learn from kidney organoids?
AudeDorison1235Thomas A.Forbes1245Melissa H.Little1235
Multiple molecular mechanisms are involved in the activation of the kidney sodium-chloride cotransporter by hypokalemia
Adrián R.Murillo-de-Ozores12HéctorCarbajal-Contreras13Germán R.Magaña-Ã�vila12RaquelValdés14Leoneli I.Grajeda-Medina1NormaVázquez4TeresaZariñán5AlejandroLópez-Saavedra6AvikaSharma7Dao-HongLin8Wen-HuiWang8EricDelpire9David H.Ellison71011GerardoGamba134MarÃaCastañeda-Bueno1
Persistent DNA damage underlies tubular cell polyploidization and progression to chronic kidney disease in kidneys deficient in the DNA repair protein FAN1
MerlinAirik1Yu LengPhua2Amy B.Huynh1Blake T.McCourt1Brittney M.Rush3Roderick J.Tan3JerryVockley4Susan L.Murray5AnthonyDorman5Peter J.Conlon5RannarAirik16
Novel gold-platinum nanoparticles serve as broad-spectrum antioxidants for attenuating ischemia reperfusion injury of the kidney
ShijianFeng125YingQu15BingyangChu1XiaotingChen3ZiyanYang4PeiwenLi4PeiyuWang4QiyuHe1YushiHe1TaoLin12ZhongliHuang12ZhiyongQian1
Kidney targeting of formoterol containing polymeric nanoparticles improves recovery from ischemia reperfusion-induced acute kidney injury in mice
Ernest L.Vallorz1JaroslavJanda1Heidi M.Mansour123Rick G.Schnellmann1234
Targeting inflammatory monocytes by immune-modifying nanoparticles prevents acute kidney allograft rejection
ChristinaLai12Steven J.Chadban12Yik WenLoh1Tony King-TakKwan1ChuanminWang1JulianSinger12PaulaNiewold3ZhengLing3AlannaSpiteri3DanielGetts3Nicholas Jonathan ColeKing34HuilingWu12
Expression of active B-Raf proto-oncogene in kidney collecting ducts induces cyst formation in normal mice and accelerates cyst growth in mice with polycystic kidney disease
Stephen C.Parnell15ArchanaRaman25YanZhang3Emily A.Daniel3YuqiaoDai3AditiKhanna3Gail A.Reif3Jay L.Vivian4Timothy A.Fields4Darren P.Wallace23
Arterial stiffness, endothelial dysfunction and impaired fibrinolysis are pathogenic mechanisms contributing to cardiovascular risk in ANCA-associated vasculitis
Tariq E.Farrah123VanessaMelville2AlicjaCzopek1HenryFok4LorraineBruce1Nicholas L.Mills15Matthew A.Bailey1David J.Webb12James W.Dear1NeerajDhaun123
Associations between nephron number and podometrics in human kidneys
KotaroHaruhara12GoKanzaki2TakayaSasaki2SaekoHatanaka2YusukeOkabayashi23Victor G.Puelles13Ian S.Harper4AkiraShimizu5Luise A.Cullen-McEwen1NobuoTsuboi2TakashiYokoo2John F.Bertram16
The Dutch Childhood Cancer Survivor Study (DCCSS)-LATER 2 kidney analysis examined long-term glomerular dysfunction in childhood cancer survivors
Esmee C.M.Kooijmans12Helena J.H.van der Pal2Saskia M.F.Pluijm2Margrietvan der Heiden-van der Loo23Leontien C.M.Kremer245DorineBresters26Elinevan Dulmen-den Broeder1Marry M.van den Heuvel-Eibrink27Jacqueline J.Loonen8MarloesLouwerens9Sebastian J.C.Neggers10CécileRonckers2Wim J.E.Tissing211Andrica C.H.de Vries27Gertjan J.L.Kaspers12Margreet A.Veening1213ArendBökenkamp1213Dutch LATER study group
Kidney outcomes in patients with diabetes mellitus did not differ between individual sodium-glucose cotransporter-2 inhibitors
YutaSuzuki1HidehiroKaneko12AkiraOkada3SatoshiMatsuoka1KatsuhitoFujiu12NobuakiMichihata4TaisukeJo4NorifumiTakeda1HiroyukiMorita1KoichiNode5MasaomiNangaku6HideoYasunaga7IsseiKomuro1
Lipidomic profiling in the Strong Heart Study identified American Indians at risk of chronic kidney disease
WenjieZeng1Habtamu B.Beyene2MikkoKuokkanen3GuanhongMiao1Dianna J.Magliano2Jason G.Umans45NoraFranceschini6Shelley A.Cole7GeorgeMichailidis8Elisa T.Lee9Barbara V.Howard45OliverFiehn10Joanne E.Curran3JohnBlangero3Peter J.Meikle2JinyingZhao1
Identification of 969 protein quantitative trait loci in an African American population with kidney disease attributed to hypertension
AdityaSurapaneni12PascalSchlosser13LindaZhou1CelinaLiu1NilanjanChatterjee4Dan E.Arking5DiptavoDutta3JosefCoresh14Eugene P.Rhee6Morgan E.Grams12
A randomized controlled pilot trial of anakinra for hemodialysis inflammation
Laura M.Dember123AdrianaHung456RajnishMehrotra78Jesse Y.Hsu23Dominic S.Raj9David M.Charytan10Finnian R.Mc Causland1011RenuRegunathan-Shenk9J. RichardLandis23Paul L.Kimmel12Alan S.Kliger1314JonathanHimmelfarb7T. AlpIkizler456Hemodialysis Novel Therapies Consortium
A rapid decline in the anti–receptor-binding domain of the SARS-CoV-2 spike protein IgG titer in kidney transplant recipients after tixagevimab–cilgavimab administration
IliesBenotmane12AurélieVelay23Gabriela-GautierVargas1JérômeOlagne1NoëlleCognard1FrançoiseHeibel1LauraBraun-Parvez1JonasMartzloff1PeggyPerrin1RomainPszczolinski1BrunoMoulin12SamiraFafi-Kremer23SophieCaillard12
Pregnancy after kidney transplantation: more attention is needed for long-term follow-up of the offspring
Jildau R.Meinderts1Michiel F.Schreuder2Margriet F.C.de Jong1
letter to the editor
Magdalene M.Assimon1Patrick H.Pun23LilyWang4Sana M.Al-Khatib35M. AlanBrookhart6David J.Weber7Wolfgang C.Winkelmayer8Jennifer E.Flythe14
Glomerulocystic kidney disease
MarcScheen1ArianePaoloni-Giacobino2Elsa GonzalezNguyen-Tang3JulianVidal4SophieDe Seigneux1FadiHaidar1
Tumor-induced osteomalacia
Anand K.Annamalai1AjitShinto2SubramanianAram3Veeranathevar AnanjiPrabhu3RadhakrishnanSanthi4ChandrasekaranGopalakrishnan3MathirajanChelian3Kaliappan GurusamySrinivasan5
The Case | Is this hemolytic uremic syndrome?
RalphKettritz13WiebkeDüttmann1AnnaBrand2Friedrich C.Luft13
The Case | An 80-year-old man with obstructive uropathy
CamilleSaint-Jacques1AudreyUzan2EliseMarechal1VincentFrochot1Jean-PhilippeHaymann13OlivierTraxer23MichelDaudon1EmmanuelLetavernier13
